SecBot SecBot
DEFA14A ·Filed Oct 29, 2026

VASO

VASO Corp
NEUTRAL
Impact 2/10
Horizondays Processed7d 8h ago SEC0001213900-26-113713
Proxy solicitation materials
Actionable Insight • Neutral

Monitor the annual meeting outcome on December 8 for any unexpected vote results or dissident activity, though none is indicated in this filing.

DirectionNeutral
Confidencehigh
Horizondays

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK AT ENTRY AT T+5
Entry
$0.2900
T+0 close · Oct 29, 2026 · via day close
Latest settled
0.00%
T+5 · $0.2900
vs SPY
+4.73%
α at T+5
Next horizon
T+20
in 21d
  1. T+0 · Oct 29 $0.2900entry
  2. T+1 · 7d ago 0.00%α +1.77% · $0.2900
  3. T+5 · 15h ago 0.00%α +4.73% · $0.2900
  4. T+20 · in 21d Pending
  5. T+60 · in 3mo Pending

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Vaso Corp filed definitive additional proxy soliciting materials (DEFA14A) on October 29, 2026, reminding shareholders to vote at the December 8, 2026 annual meeting. The sole agenda item is the election of two Class III directors, Jun Ma and Shaun McMeans, as recommended by the board. This filing is a routine reminder notice and does not contain any new material information beyond what was in the previously filed definitive proxy statement.

Key Financial Metrics

Vote
director election
Meeting
2026-12-08
Seats Contested
2

Key Facts

  • Annual meeting scheduled for December 8, 2026 at 10:00 AM Eastern Time
  • Record date and voting deadline: December 7, 2026 at 11:59 PM ET
  • Board recommends voting FOR nominees Jun Ma and Shaun McMeans
  • Meeting location: 730 Third Ave, Room 2E, New York, NY 10017
  • This is a DEFA14A filing, a definitive additional proxy soliciting material

Financial Impact

No financial impact; routine proxy solicitation notice

Risk Factors

  • No material risks identified; this is a routine proxy reminder

Market Snapshot

Exchange
OTC
Sector
Electromedical & Electrotherapeutic Apparatus

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
DEFA14A Filing (Primary)0001213900-26-113713
Document: 0001213900-26-113713-index-headers.html0001213900-26-113713
Document: 0001213900-26-113713-index.html0001213900-26-113713
Document: 0001213900-26-113713.txt0001213900-26-113713
3 reports for VASO
Performance horizon
Filters
Rows
Reports for VASO, sortable and filterable
TypeNow
Oct 29, 2026
7d ago
DEFA14A
NEUTRAL ★ 2/10
$0.2900awaiting T+20awaiting T+20$0.2900 (−0.00%)
Oct 29, 2026
7d ago
DEF 14A
NEUTRAL ★ 2/10
$0.2900awaiting T+20awaiting T+20$0.2900 (−0.00%)
May 8, 2026
25w ago
8-K
NEUTRAL ★ 2/10
$0.2000 $0.1900▼ −5.00%▼ −4.70%$0.2900 (+45.00%)
Showing 3 of 3

US Market Status

Market Closed · Opens Mon (59h 41m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Oct 29, 2026